Minister Daly leads Enterprise Ireland Trade Visit to Arab Health, Dubai and puts the spotlight on Irish Medtech innovations
29th January 2018
Aerogen opens new office in Dubai and Ovelle Pharmaceuticals signs contract with Life Pharmacy during largest event of its kind in the MENA region.
Jim Daly T.D. Minister of State at the Department of Health is leading an Enterprise Ireland trade visit to Arab Health in Dubai, the largest healthcare exhibition and conference in the MENA region, today, Monday 29th January 2018.
The trade visit focuses on maximising business opportunities for the 20 Enterprise Ireland clients exhibiting and participating at Arab Health. Attendance of the healthcare exhibition and conference is expected to surpass the 2017 levels of 4,000 exhibitors and over 130,000 visitors from 163 countries.
Prior to visiting the Enterprise Ireland stand at Arab Health, Minister Daly officially opened the Middle East Commercial office of Aerogen, the world leader in aerosol drug delivery. Aerogen is seeing growing demand across all markets but has seen outstanding growth across the entire Gulf region according to John Power, Aerogen CEO and Founder; “There’s a really great opportunity for us in the Middle East, it is an extremely important market for Aerogen, and we look forward to strengthening our commitment here over the coming years.”
During the Arab Health show, Minister Daly witnessed a contract signing between Ovelle Pharmaceuticals and Life Pharmacy.
Based in Dundalk Ovelle Pharmaceuticals is a fast growing and highly adaptive international skincare company. This deal coincides with the launch of their range of innovative skincare brands in Life Pharmacy retail outlets.
Life Healthcare Group is the largest retail chain of pharmacies in Middle East with 130+ pharmacies, Health & Wellness Stores and Hypermarkets.
Minister Daly will also participate in a number of engagements to build on the strong relationship Enterprise Ireland has with healthcare institutions and government bodies in the UAE including; the Dubai Ambulance and National Ambulance, Abu Dhabi; the Dubai Health Authority and the Dubai Police Medical Services.
Speaking on his arrival at Arab Health Minister Daly said; “The United Arab Emirates presents growth opportunities for Irish companies and is already a significant consumer of Irish goods. In 2016 Enterprise Ireland client company exports to the UAE were in excess of €123M. By providing a platform for Irish companies to present their solutions and network with leading healthcare professionals, Arab Health is an ideal opportunity to position Ireland as a source of world-class high tech products and solutions for the UAE healthcare sector. I look forward to meeting with representatives from the UAE authorities and industry to promote Irish innovative healthcare solutions over the coming days.”
The exhibition has become a strategically important event for established companies in the region to build on existing market presence as well as for smaller companies and high-potential start-ups, providing them with a holistic overview of the opportunities and market environment in the region and access to key players and potential partners.
Enterprise Ireland will host a stand for 10 client companies at Arab Health 2018; Aerogen, Amray Medical, CF Pharma, EFESO Pharma & Labs (formerly BSM), Fleming Medical, LLR-G5, Maria Medical Technology, Novaerus, Ovelle Pharmaceuticals and 4 Medicine & Clinical Innovation Ltd.
Amongst the Irish exhibits will be; drug delivery systems, medical devices, digital health technologies and pharmaceutical products.
Speaking from the event in Dubai, Dr. Tom Kelly, Divisional Manager of Lifesciences at Enterprise Ireland said; ’Ireland has over 250 highly innovative life sciences companies designing, developing and manufacturing healthcare products and services which Enterprise Ireland sees a demand for in this region. We are keen to use Arab Health as an opportunity to promote Ireland to potential healthcare buyers. Supporting our client companies to identify new markets for their products and services is part of Enterprise Ireland’s strategy to enable our clients to build scale and expand global reach as part of our response to the UK’s decision to leave the EU”.
For more information contact: